Ayala Pharmaceuticals Analyst Ratings
BenzingaNov 16, 2023 14:11 ET
Ladenburg Thalmann Upgrades Advaxis to Buy, Announces $4 Price Target
BenzingaMay 30, 2023 07:38 ET
Oppenheimer Downgrades Ayala Pharmaceuticals to Perform From Outperform After News of Advaxis Merger Agreement, Price Target Is $16
MT NewswiresOct 31, 2022 08:48 ET
No Data
No Data